Terms: = Kidney tumors AND GPC3, OCI-5, 2719, ENSG00000147257, SGBS, SGB, DGSX, SDYS, P51654, AC002420_1, SGBS1
28 results:
1. Glutamine synthetase and hepatocellular carcinoma.
Jiang J; Hu Y; Fang D; Luo J
Clin Res Hepatol Gastroenterol; 2023 Dec; 47(10):102248. PubMed ID: 37979911
[TBL] [Abstract] [Full Text] [Related]
2. kidney-type glutaminase is a biomarker for the diagnosis and prognosis of hepatocellular carcinoma: a prospective study.
Zhang L; Su K; Liu Q; Li B; Wang Y; Cheng C; Li Y; Xu C; Chen J; Wu H; Zhu M; Mai X; Cao Y; Peng J; Yue Y; Ding Y; Yu D
BMC Cancer; 2023 Nov; 23(1):1081. PubMed ID: 37946141
[TBL] [Abstract] [Full Text] [Related]
3. Site-Specifically Conjugated Single-Domain Antibody Successfully Identifies Glypican-3-Expressing Liver Cancer by Immuno-PET.
Fayn S; King AP; Gutsche NT; Duan Z; Buffington J; Olkowski CP; Fu Y; Hong J; Sail D; Baidoo KE; Swenson RE; Cheloha RW; Ho M; Choyke PL; Escorcia FE
J Nucl Med; 2023 Jul; 64(7):1017-1023. PubMed ID: 36997331
[TBL] [Abstract] [Full Text] [Related]
4. Attenuation of cancer proliferation by suppression of glypican-1 and its pleiotropic effects in neoplastic behavior.
Cheng F; Hansson VC; Georgolopoulos G; Mani K
Oncotarget; 2023 Mar; 14():219-235. PubMed ID: 36944188
[TBL] [Abstract] [Full Text] [Related]
5. Nanobody-based CAR T cells targeting intracellular tumor antigens.
Li H; Zhong D; Luo H; Shi W; Xie S; Qiang H; Zhu L; Gao L; Liu J; Sun S; Ding Z; Yang X; Lu X
Biomed Pharmacother; 2022 Dec; 156():113919. PubMed ID: 36411612
[TBL] [Abstract] [Full Text] [Related]
6. gpc3-targeted immunoPET imaging of hepatocellular carcinomas.
An S; Zhang D; Zhang Y; Wang C; Shi L; Wei W; Huang G; Liu J
Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2682-2692. PubMed ID: 35147737
[TBL] [Abstract] [Full Text] [Related]
7. Ceruloplasmin overexpression is associated with oncogenic pathways and poorer survival rates in clear-cell renal cell carcinoma.
Zhang Y; Chen Z; Chen JG; Chen XF; Gu DH; Liu ZM; Gao YD; Zheng B
FEBS Open Bio; 2021 Nov; 11(11):2988-3004. PubMed ID: 34449964
[TBL] [Abstract] [Full Text] [Related]
8. AFP-producing Xp11 translocation renal cell carcinoma: Case report and review of the literature.
Zhang HZ; Wang SY
Curr Probl Cancer; 2021 Jun; 45(3):100689. PubMed ID: 33388149
[TBL] [Abstract] [Full Text] [Related]
9. Glypican-3-Targeted Alpha Particle Therapy for Hepatocellular Carcinoma.
Bell MM; Gutsche NT; King AP; Baidoo KE; Kelada OJ; Choyke PL; Escorcia FE
Molecules; 2020 Dec; 26(1):. PubMed ID: 33374953
[TBL] [Abstract] [Full Text] [Related]
10. Hepatoid adenocarcinoma of the renal pelvis in a 59-year-old male with nephrolithiasis: Case report and review of the literature.
Huang J; Zhu R; Wu R; Li R; Yao N; Deng S
Curr Probl Cancer; 2019 Oct; 43(5):471-476. PubMed ID: 30683324
[TBL] [Abstract] [Full Text] [Related]
11. Glypican-3 mRNA expression level in Wilms tumor: correlation with histological type, stage, and outcome.
Wari MN; Vallonthaiel AG; Ahmed A; Saxena D; Iyer VK; Mathur SR; Agarwala S; Bakhshi S; Srinivas V; Chattopadhyaya P; Sharma A; Gupta SD; Dinda A
Pediatr Surg Int; 2017 Jun; 33(6):695-703. PubMed ID: 28432433
[TBL] [Abstract] [Full Text] [Related]
12. Simultaneous double primary clear cell carcinomas of liver and kidney: a case report and review of literature.
Zhang W; Wang Q; Jiang YX; Lu Q; Yu WJ; Liu Y; Liu YL; Zhao H; Zhuang J; Li YJ
Int J Clin Exp Pathol; 2015; 8(1):995-9. PubMed ID: 25755808
[TBL] [Abstract] [Full Text] [Related]
13. Glypican 3 overexpression in primary and metastatic Wilms tumors.
Tretiakova M; Zynger DL; Luan C; Andeen NK; Finn LS; Kocherginsky M; Teh BT; Yang XJ
Virchows Arch; 2015 Jan; 466(1):67-76. PubMed ID: 25366870
[TBL] [Abstract] [Full Text] [Related]
14. Glypican 3 expression in pediatric malignant solid tumors.
Kinoshita Y; Tanaka S; Souzaki R; Miyoshi K; Kohashi K; Oda Y; Nakatsura T; Taguchi T
Eur J Pediatr Surg; 2015 Feb; 25(1):138-44. PubMed ID: 25344940
[TBL] [Abstract] [Full Text] [Related]
15. gpc3 reduces cell proliferation in renal carcinoma cell lines.
Valsechi MC; Oliveira AB; Conceição AL; Stuqui B; Candido NM; Provazzi PJ; de Araújo LF; Silva WA; Calmon Mde F; Rahal P
BMC Cancer; 2014 Aug; 14():631. PubMed ID: 25168166
[TBL] [Abstract] [Full Text] [Related]
16. Wilms' tumor in patients with 9q22.3 microdeletion syndrome suggests a role for PTCH1 in nephroblastomas.
Isidor B; Bourdeaut F; Lafon D; Plessis G; Lacaze E; Kannengiesser C; Rossignol S; Pichon O; Briand A; Martin-Coignard D; Piccione M; David A; Delattre O; Jeanpierre C; Sévenet N; Le Caignec C
Eur J Hum Genet; 2013 Jul; 21(7):784-7. PubMed ID: 23169491
[TBL] [Abstract] [Full Text] [Related]
17. A new membrane re-anchored protein originating from gpc3 against hepatoma cells HepG2.
Yang D; Yang J; Lu F; Li C; Yang J; Liang J
Mol Med Rep; 2011; 4(6):1067-73. PubMed ID: 21904776
[TBL] [Abstract] [Full Text] [Related]
18. Adjuvant radiotherapy for gastric cancer: A dosimetric comparison of 3-dimensional conformal radiotherapy, tomotherapy and conventional intensity modulated radiotherapy treatment plans.
Dahele M; Skinner M; Schultz B; Cardoso M; Bell C; Ung YC
Med Dosim; 2010; 35(2):115-21. PubMed ID: 19931023
[TBL] [Abstract] [Full Text] [Related]
19. Perlman syndrome: report, prenatal findings and review.
Alessandri JL; Cuillier F; Ramful D; Ernould S; Robin S; de Napoli-Cocci S; Rivière JP; Rossignol S
Am J Med Genet A; 2008 Oct; 146A(19):2532-7. PubMed ID: 18780370
[TBL] [Abstract] [Full Text] [Related]
20. Glypican-3 is expressed in chromophobe renal cell carcinomas.
Okoń K
Pol J Pathol; 2008; 59(1):15-20. PubMed ID: 18655366
[TBL] [Abstract] [Full Text] [Related]
[Next]
